FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Metformin Hydrochloride Extended Release Tablets
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Teva Pharmaceuticals (New 06/24/2020)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
Metformin Hydrochloride Tablet Extended Release, 750 mg per tablet, (NDC 0093-7212-01), 100 count per bottle 07/22/2019 Teva made a business decision to discontinue the drug product.
Metformin Hydrochloride Tablet Extended Release, 500 mg per tablet, (NDC 0093-7267-01), 100 count per bottle 07/22/2019 Teva made a business decision to discontinue the drug product.
Metformin Hydrochloride Tablet Extended Release, 500 mg per tablet, (NDC 0093-7267-10), 1000 count per bottle 07/22/2019 Teva made a business decision to discontinue the drug product.
750mg tablets (NDC 2037-577-10) and (NDC 62037-577-01 ) 06/24/2020 Teva made a business decision to discontinue the product.
500mg tablets (NDC 62037-571-01) and (NDC 62037-571-10) 06/24/2020 Teva made a business decision to discontinue the product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English